Real-World Comparative Analysis of Liposomal Doxorubicin Versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma

J Acquir Immune Defic Syndr. 2025 Feb 1;98(2):e4-e6. doi: 10.1097/QAI.0000000000003557.
No abstract available